U.S. markets closed

Willow Biosciences Inc. (CANSF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.1100+0.0550 (+5.21%)
At close: 2:33PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/7/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
131.59M88.62M43.61M31.77M26.70M
Enterprise Value 3
119.35M81.95M34.77M20.81M13.63M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
10.62k37.85k27.29k7.87k7.36k
Price/Book (mrq)
N/A30.115.322.171.68
Enterprise Value/Revenue 3
11.93k10.73k173.86kN/A6.31k
Enterprise Value/EBITDA 7
-3.88-3.90-11.10-6.52-4.05

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 331.67%
S&P500 52-Week Change 344.45%
52 Week High 31.7540
52 Week Low 30.8090
50-Day Moving Average 31.1315
200-Day Moving Average 31.1791

Share Statistics

Avg Vol (3 month) 394.3k
Avg Vol (10 day) 329.3k
Shares Outstanding 5123.27M
Implied Shares Outstanding 6N/A
Float 82.32M
% Held by Insiders 126.82%
% Held by Institutions 11.61%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 20, 2019
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-123,771.44%

Management Effectiveness

Return on Assets (ttm)-26.54%
Return on Equity (ttm)-198.95%

Income Statement

Revenue (ttm)14k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)177.80%
Gross Profit (ttm)10k
EBITDA -15.02M
Net Income Avi to Common (ttm)-43.84M
Diluted EPS (ttm)-0.3900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)47.05M
Total Cash Per Share (mrq)0.42
Total Debt (mrq)808k
Total Debt/Equity (mrq)3.52
Current Ratio (mrq)27.15
Book Value Per Share (mrq)0.20

Cash Flow Statement

Operating Cash Flow (ttm)-13.34M
Levered Free Cash Flow (ttm)-7.58M